floxuridine has been researched along with Adenocarcinoma, Mucinous in 7 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"With a diagnosis of advanced breast cancer with skin invasion, she underwent right mastectomy with a free skin graft." | 1.32 | Massive mucinous carcinoma of the breast untreated for 6 years. ( Sakaguchi, K; Tsuchie, K; Yoneyama, F, 2003) |
" Pharmacokinetic studies after administration of S-1 revealed high and prolonged plasma 5-FU levels." | 1.32 | S-1-induced, prolonged complete regression of lung metastasis from gastric cancer refractory to 5'-DFUR: a case report with pharmacokinetic study. ( Ajani, JA; Itoh, N; Itoi, H; Shirasaka, T; Ueda, Y; Yamagishi, H; Yamashita, T, 2004) |
"The overall response rate was 20." | 1.28 | [Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer]. ( Ikeda, M; Noda, K; Ochiai, K; Saito, Y; Sato, A; Suzuki, M; Takada, M; Terashima, Y; Yajima, A; Yoshida, K, 1991) |
" 5'-DFUR was administered three or four times a day at a daily dosage of 600 to 1200 mg." | 1.27 | [Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group]. ( Gocho, Y; Ishitani, K; Kogo, Y; Kouda, K; Koyama, R; Matsuda, M; Nagai, T; Niitsu, Y; Saijo, N; Urushizaki, I, 1985) |
" 5'-DFUR (5'-deoxy-5-fluorouridine) was administered orally at 1,200 mg/day for 23 weeks, for a total dosage of 110." | 1.27 | [A case of gastric cancer in which long-term administration of 5'-deoxy-5-fluorouridine (5'-DFUR) proved effective]. ( Iwao, N; Koda, T; Kurahori, T; Miyaji, J; Okahisa, N; Sonoda, T; Sumi, S; Yanagimoto, H, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 1 (14.29) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wagner, PL | 1 |
Jones, D | 1 |
Aronova, A | 1 |
Shia, J | 1 |
Weiser, MR | 1 |
Temple, LK | 1 |
Chung, KY | 1 |
O'Reilly, EM | 1 |
Kelsen, D | 1 |
Paty, PB | 1 |
Nash, GM | 1 |
Yoneyama, F | 1 |
Tsuchie, K | 1 |
Sakaguchi, K | 1 |
Ueda, Y | 1 |
Yamagishi, H | 1 |
Yamashita, T | 1 |
Itoh, N | 1 |
Itoi, H | 1 |
Shirasaka, T | 1 |
Ajani, JA | 1 |
Tanaka, K | 1 |
Noura, S | 1 |
Ohue, M | 1 |
Takachi, K | 1 |
Kishi, K | 1 |
Eguchi, H | 1 |
Yamada, T | 1 |
Miyashiro, I | 1 |
Yano, M | 1 |
Ohigashi, H | 1 |
Sasaki, Y | 1 |
Ishikawa, O | 1 |
Imaoka, S | 1 |
Kameyama, M | 1 |
Murata, K | 1 |
Noda, K | 1 |
Ikeda, M | 1 |
Saito, Y | 1 |
Yajima, A | 1 |
Sato, A | 1 |
Suzuki, M | 1 |
Terashima, Y | 1 |
Ochiai, K | 1 |
Yoshida, K | 1 |
Takada, M | 1 |
Urushizaki, I | 1 |
Kogo, Y | 1 |
Kouda, K | 1 |
Ishitani, K | 1 |
Niitsu, Y | 1 |
Matsuda, M | 1 |
Gocho, Y | 1 |
Koyama, R | 1 |
Nagai, T | 1 |
Saijo, N | 1 |
Koda, T | 1 |
Kurahori, T | 1 |
Iwao, N | 1 |
Sumi, S | 1 |
Sonoda, T | 1 |
Yanagimoto, H | 1 |
Miyaji, J | 1 |
Okahisa, N | 1 |
7 other studies available for floxuridine and Adenocarcinoma, Mucinous
Article | Year |
---|---|
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Appendiceal N | 2012 |
Massive mucinous carcinoma of the breast untreated for 6 years.
Topics: Adenocarcinoma, Mucinous; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Floxurid | 2003 |
S-1-induced, prolonged complete regression of lung metastasis from gastric cancer refractory to 5'-DFUR: a case report with pharmacokinetic study.
Topics: Adenocarcinoma, Mucinous; Administration, Oral; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv | 2004 |
[A case of chemoradiation with tissue expander for local reccurence of rectal cancer].
Topics: Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antine | 2005 |
[Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Administration, Oral; Adult; Aged; Antineoplastic Agents; | 1991 |
[Clinical phase II study of 5'-DFUR for cancer of the digestive organs by a cooperative study group].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Colo | 1985 |
[A case of gastric cancer in which long-term administration of 5'-deoxy-5-fluorouridine (5'-DFUR) proved effective].
Topics: Adenocarcinoma, Mucinous; Antineoplastic Agents; Female; Floxuridine; Humans; Long-Term Care; Middle | 1987 |